Asia Pacific Proteomics Market worth USD 16.61 billion by 2030
The report "Asia Pacific Proteomics Market by Instrumentation Technology [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030" is projected to reach USD 16.61 billion by 2030 from USD 8.57 billion in 2025, at a CAGR of 14.1% during the forecast period.
Browse 983 market data Tables and 57 Figures spread through 781 Pages and in-depth TOC on "Asia Pacific Proteomics Market, By Instrumentation Technology [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-proteomics-market-186411434.html
The Asia Pacific proteomics market is experiencing growth, driven by several key factors, including rising adoption of mass spectrometry-based and immunoassay-based proteomics in academic and hospital research labs and strong government funding for precision medicine, cancer research, and population-scale health initiatives.
The core proteomics services segment accounted for a larger share of the Asia Pacific proteomics market, by service, in 2024.
By service, the proteomics market is segmented into core proteomics services and bioinformatics services. In 2024, core proteomics services were the leading contributor in the service segment due to the heavy reliance on centralized facilities by academic institutes, hospitals, and CROs. These core labs offer access to state-of-the-art mass spectrometry resources and infrastructure. They provide experienced bioinformatics support, enabling cost-efficient, high-quality protein analysis for biopharma firms and scientists who do not have a major infrastructure of their own.
The bioinformatics tools segment is estimated to lead the Asia Pacific proteomics market, by software.
By software, the market is divided into bioinformatics tools and bioinformatics databases. Of these, the bioinformatics tools segment is estimated to hold a larger share of the market due to the growing volume and complexity of proteomics data, which increases demand for advanced data processing, visualization, and integration platforms. These tools are essential for interpreting high-throughput proteomics results, enabling protein identification, quantification, pathway analysis, and seamless integration with genomic and clinical datasets across research and translational applications.
China accounted for the largest share of the Asia Pacific proteomics market in 2024.
The Asia Pacific proteomics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2024, China held the largest share of the Asia Pacific proteomics market, driven by substantial government investment in precision medicine, rapid growth of biopharmaceutical and CRO capabilities, and the availability of large patient cohorts for clinical research. Widespread adoption of high-throughput proteomics platforms across academic institutes, hospitals, and pharmaceutical companies continues to reinforce China’s leading position in the region.
Key players in the Asia Pacific proteomics market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Bruker Corporation (US), Shimadzu Corporation (Japan), Bio-Rad Laboratories Inc. (US), Waters Corporation (US), and QIAGEN (Netherlands).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Proteomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
